For research use only. Not for therapeutic Use.
LY392098（Cat No.:I007850）is a selective antagonist of the glucagon-like peptide-1 (GLP-1) receptor, a key receptor involved in regulating glucose metabolism and insulin secretion. By blocking GLP-1 receptor activation, LY392098 has been studied for its potential role in treating type 2 diabetes and obesity. GLP-1 typically promotes insulin release and helps control blood sugar levels, so inhibiting its receptor may offer an alternative approach to managing glucose levels. Early-stage studies have shown its promise in regulating metabolic processes, but further clinical trials are necessary to evaluate its safety, efficacy, and long-term benefits in diabetes treatment.
| Catalog Number | I007850 |
| CAS Number | 211311-39-6 |
| Synonyms | LY392098; LY 392098; LY-392098.;N-{2-[4-(2-fluorophenyl)phenyl]propyl}propane-2-sulfonamide |
| Molecular Formula | C18H22FNO2S |
| Purity | ≥95% |
| Target | Neuronal Signaling |
| Solubility | Soluble in DMSO |
| Storage | 0 - 4 °C for short term, or -20 °C for long term |
| IUPAC Name | N-[2-[4-(2-fluorophenyl)phenyl]propyl]propane-2-sulfonamide |
| InChI | InChI=1S/C18H22FNO2S/c1-13(2)23(21,22)20-12-14(3)15-8-10-16(11-9-15)17-6-4-5-7-18(17)19/h4-11,13-14,20H,12H2,1-3H3 |
| InChIKey | CECANHFDVPUVMI-UHFFFAOYSA-N |
| SMILES | CC(C)S(=O)(=O)NCC(C)C1=CC=C(C=C1)C2=CC=CC=C2F |
